Literature DB >> 9810411

Seroprevalence study of HTLV-1 and HIV infection in blood donors and patients with lymphoid malignancies in Lagos, Nigeria.

H I Analo1, A S Akanmu, I Akinsete, O S Njoku, C C Okany.   

Abstract

OBJECTIVE: To document the seroprevalence of HTLV-1 and HIV in blood donors and in patients with lymphoma and leukaemia in Lagos metropolis.
DESIGN: Cross sectional.
SETTING: The Lagos University Teaching Hospital (LUTH) and General Hospital, Lagos (GH).
SUBJECTS: 406 apparently healthy voluntary blood donors from the LUTH and GH and 30 patients [20 patients with histological diagnosis of Non-Hodgkin's Lymphoma (NHL) and 10 patients with diagnosis of Chronic Lymphocytic Leukaemia (CLL)] were recruited at LUTH. MAIN OUTCOME MEASURES: HTLV-1 and HIV-1 seroprevalence.
RESULTS: Out of 406 donors, three (0.7%) were positive for HTLV-1 and 20 (4.9%) were positive for HIV-1. None of the 30 patients with NHL or CLL were positive for HTLV-1. Five of NHL patients were positive for HIV-1.
CONCLUSION: HTLV-1 seroprevalence is low among Lagos donors. Routine screening of donors for this virus will not be cost effective. NHL is one of the AIDS related malignancies which has been documented in this study.

Entities:  

Mesh:

Year:  1998        PMID: 9810411

Source DB:  PubMed          Journal:  Cent Afr J Med        ISSN: 0008-9176


  9 in total

Review 1.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

2.  Human T-cell lymphotropic virus in a population of pregnant women and commercial sex workers in South Western Nigeria.

Authors:  J C Forbi; A B Odetunde
Journal:  Afr Health Sci       Date:  2007-09       Impact factor: 0.927

3.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

4.  Seroprevalence of human T lymphotropic virus antibodies among healthy blood donors at a tertiary centre in Lagos, Nigeria.

Authors:  Idris Durojaiye; Akinsegun Akinbami; Adedoyin Dosunmu; Sarah Ajibola; Adewumi Adediran; Ebele Uche; Olajumoke Oshinaike; Majeed Odesanya; Akinola Dada; Olaitan Okunoye
Journal:  Pan Afr Med J       Date:  2014-04-21

5.  Seroprevalence of human T-cell lymphoma/leukemia virus type-1 (HTLV-1) antibodies among blood donors at Enugu, Nigeria.

Authors:  Augustine Ejike Okoye; Obike Godswill Ibegbulam; Robinson Chukwudi Onoh; Ngozi Immaculata Ugwu; Chukwudi Simon Anigbo; Charles Emeka Nonyelu
Journal:  J Blood Med       Date:  2015-01-19

6.  Seroprevalence and correlates of human T-cell lymphoma/leukemia virus type 1 antibodies among pregnant women at the University of Nigeria Teaching Hospital, Enugu, Nigeria.

Authors:  Augustine Ejike Okoye; Obike Godswill Ibegbulam; Robinson Chukwudi Onoh; Paul Olisaemeka Ezeonu; Ngozi I Ugwu; Lucky Osaheni Lawani; Chukwudi Simon Anigbo; Charles E Nonyelu
Journal:  Int J Womens Health       Date:  2014-09-18

7.  Molecular Detection and Clinical Implications of HTLV-1 Infections among Antiretroviral Therapy-Naïve HIV-1-Infected Individuals in Abuja, Nigeria.

Authors:  Idris Abdullahi Nasir; Abdurrahman Elfulaty Ahmad; Anthony Uchenna Emeribe; Muhammad Sagir Shehu; Jessy Thomas Medugu; Adamu Babayo
Journal:  Virology (Auckl)       Date:  2015-12-14

8.  Seroprevalence of human T-lymphotropic virus antibodies among patients with lymphoid malignancies at a tertiary center in Lagos, Nigeria.

Authors:  Akinsegun Akinbami; Idris Durojaiye; Adedoyin Dosunmu; Sarah John-Olabode; Adewumi Adediran; Olajumoke Oshinaike; Ebele Uche; Akinola Dada; Mojeed Odesanya; Olaitan Okunoye
Journal:  J Blood Med       Date:  2014-09-05

Review 9.  Re-emergence of human T-lymphotropic viruses in West Africa.

Authors:  Nneoma Confidence JeanStephanie Anyanwu; Elijah Ekah Ella; Aghogho Ohwofasa; Maryam Aminu
Journal:  Braz J Infect Dis       Date:  2018-06-05       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.